144 related articles for article (PubMed ID: 22615588)
1. Molecular analysis of MEN1 expression in MCF7, T47D and MDA-MB 468 breast cancer cell lines treated with adriamycin using RT-PCR and immunocytochemistry.
Azizi E; Namazi A; Kaabinejadian S; Fouladdel Sh; Rezaei P; Ramezani M
Daru; 2010; 18(1):17-22. PubMed ID: 22615588
[TBL] [Abstract][Full Text] [Related]
2. Comparative EPR Studies on the Influence of Genistein on Free Radicals in Non-Irradiated and UV-Irradiated MCF7, T47D and MDA-MB-231 Breast Cancer Cells.
Jurzak M; Ramos P; Pilawa B; Bednarek IA
Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540131
[TBL] [Abstract][Full Text] [Related]
3. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
4. Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231).
Takabatake D; Fujita T; Shien T; Kawasaki K; Taira N; Yoshitomi S; Takahashi H; Ishibe Y; Ogasawara Y; Doihara H
Int J Cancer; 2007 Jan; 120(1):181-8. PubMed ID: 17036319
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of menin in various adrenal tumors. The role of menin in adrenal tumors.
Bhuiyan MM; Sato M; Murao K; Imachi H; Namihira H; Ishida T; Takahara J; Miyauchi A
Cancer; 2001 Sep; 92(6):1393-401. PubMed ID: 11745215
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468.
Natarajan S; Ranganathan M
Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):408-415. PubMed ID: 32686546
[TBL] [Abstract][Full Text] [Related]
7. MEN1 silencing triggers the dysregulation of mTORC1 and MYC pathways in ER+ breast cancer cells.
Abou Ziki R; Teinturier R; Luo Y; Cerutti C; Vanacker JM; Poulard C; Bachelot T; Diab-Assaf M; Treilleux I; Zhang CX; Le Romancer M
Endocr Relat Cancer; 2022 Aug; 29(8):451-465. PubMed ID: 35583188
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
9. Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer.
Tantivejkul K; Vucenik I; Eiseman J; Shamsuddin AM
Breast Cancer Res Treat; 2003 Jun; 79(3):301-12. PubMed ID: 12846414
[TBL] [Abstract][Full Text] [Related]
10. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lakins J; Lupu R
Oncol Rep; 2000; 7(1):157-67. PubMed ID: 10601611
[TBL] [Abstract][Full Text] [Related]
11. Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA/mRNA expression analysis.
Nirgude S; Desai S; Choudhary B
Cancer Rep (Hoboken); 2022 Oct; 5(10):e1596. PubMed ID: 34981672
[TBL] [Abstract][Full Text] [Related]
12. [The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro].
Tang B; Peng ZH; Jiang J
Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1545-9. PubMed ID: 16412295
[TBL] [Abstract][Full Text] [Related]
13. Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells.
Sanlioglu AD; Dirice E; Aydin C; Erin N; Koksoy S; Sanlioglu S
BMC Cancer; 2005 May; 5():54. PubMed ID: 15916713
[TBL] [Abstract][Full Text] [Related]
14. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
Jiang Q; Zhang H; Zhang P
J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
[TBL] [Abstract][Full Text] [Related]
15. Differentially expressed proteins in ER+ MCF7 and ER- MDA- MB-231 human breast cancer cells by RhoGDI-α silencing and overexpression.
Hooshmand S; Ghaderi A; Yusoff K; Thilakavathy K; Rosli R; Mojtahedi Z
Asian Pac J Cancer Prev; 2014; 15(7):3311-7. PubMed ID: 24815488
[TBL] [Abstract][Full Text] [Related]
16. P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells.
Vayssade M; Haddada H; Faridoni-Laurens L; Tourpin S; Valent A; Bénard J; Ahomadegbe JC
Int J Cancer; 2005 Oct; 116(6):860-9. PubMed ID: 15849742
[TBL] [Abstract][Full Text] [Related]
17. Hypericin Induces Apoptosis in MDA-MB-175-VII Cells in Lower Dose Compared to MDA-MB-231.
Abbasi Gamasaee N; Radmansouri M; Ghiasvand S; Shahriari F; Zare Marzouni H; Aryan H; Jangholi E; Javidi MA
Arch Iran Med; 2018 Sep; 21(9):387-392. PubMed ID: 30221528
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy cytotoxicity of human MCF-7 and MDA-MB 231 breast cancer cells is altered by osteoblast-derived growth factors.
Koutsilieris M; Reyes-Moreno C; Choki I; Sourla A; Doillon C; Pavlidis N
Mol Med; 1999 Feb; 5(2):86-97. PubMed ID: 10203574
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Receptors Are Differentially Expressed and Activated in KAIMRC1 Compared to MCF7 and MDA-MB231 Breast Cancer Cells.
Nehdi A; Ali R; Alhallaj A; Alzahrani H; Samman N; Mashhour A; Baz O; Barhoumi T; Alghanem B; Khan A; Alriyees L; Boudjelal M
Molecules; 2019 May; 24(11):. PubMed ID: 31141879
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of RPA2 promotes NF-κB activation in breast cancer by relieving the antagonistic function of menin on NF-κB-regulated transcription.
Chen CC; Juan CW; Chen KY; Chang YC; Lee JC; Chang MC
Carcinogenesis; 2017 Feb; 38(2):196-206. PubMed ID: 28007956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]